Accelerated epigenetic aging and DNA methylation alterations in Berardinelli–Seip congenital lipodystrophy
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddad016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Abeer Qannan und 13 weiteren Autor:innen. Beteiligte Einrichtung: College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar. Hauptthemen laut MEDLINE: Lipodystrophy, Congenital Generalized, Diabetes Mellitus, Type 2, GTP-Binding Protein gamma Subunits, Lipodystrophy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NIH.
Abstract (Originalsprache)
Berardinelli–Seip congenital lipodystrophy type 2 (CGL2) is a very rare human genetic disorder with potential significance to the understanding of the pathobiology of aging. CGL2 patients display characteristic progeroid features and suffer from type 2 diabetes, insulin resistance and fatty liver. In this study, we profiled genome-wide DNA methylation levels in CGL2 patients with BSCL2 mutations to study epigenetic age acceleration and DNA methylation alterations. This analysis revealed significant age acceleration in blood DNA of CGL2 patients using both first- and second-generation epigenetic clocks. We also observed a shortened lifespan of Caenorhabditis elegans following knockdown of the BSCL2 homolog seip-1 on a daf-16/forkhead box, class O mutant background. DNA methylation analysis revealed significant differentially methylated sites enriched for lyase activity, kinase regulator activity, protein kinase regulator activity and kinase activator activity. We could also observe significant hypomethylation in the promoter of the dual specificity phosphatase 22 gene when comparing CGL2 patients versus controls. We conclude that in line with the observed progeroid features, CGL2 patients exhibit significant epigenetic age acceleration and DNA methylation alterations that might affect pathways/genes of potential relevance to the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha 34110, Qatar.
- Genetic Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar.
- Computer and Systems Engineering, Alexandria University, Alexandria, Egypt.
- Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98105, USA.
- Altos Labs, San Diego, USA.
ORCID-Profile: Colette Christiansen, Andre Megarbane, Nady El Hajj
Förderung
- NIH HHS
- NCI NIH HHS
- NIH
- Qatar National Research Fund and Qatar Genome Program
Zitieren
APA
Qannan, A., Bejaoui, Y., Izadi, M., Yousri, N. A., Razzaq, A., Christiansen, C., Martin, G. M., Bell, J. T., Horvath, S., Oshima, J., Megarbane, A., Ericsson, J., Pourkarimi, E., & El Hajj, N. (2023). Accelerated epigenetic aging and DNA methylation alterations in Berardinelli–Seip congenital lipodystrophy. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad016
Vancouver
Qannan A, Bejaoui Y, Izadi M, Yousri NA, Razzaq A, Christiansen C, et al. Accelerated epigenetic aging and DNA methylation alterations in Berardinelli–Seip congenital lipodystrophy. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddad016
BibTeX
@article{Qannan2023,
author = {Qannan, Abeer and Bejaoui, Yosra and Izadi, Mahmoud and Yousri, Noha A and Razzaq, Aleem and Christiansen, Colette and Martin, George M and Bell, Jordana T and Horvath, Steve and Oshima, Junko and Megarbane, Andre and Ericsson, Johan and Pourkarimi, Ehsan and El Hajj, Nady},
title = {Accelerated epigenetic aging and DNA methylation alterations in Berardinelli–Seip congenital lipodystrophy},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddad016}
}
EUVIMED